Louise Wang Zhiying Humphrey

Array ( [id] => 8257271 [patent_doc_number] => 08206750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Charged lipoprotein complexes and their uses' [patent_app_type] => utility [patent_app_number] => 11/388135 [patent_app_country] => US [patent_app_date] => 2006-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18874 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11388135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5310166 [patent_doc_number] => 20090017447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Human Endogenous Retrovirus with Foamy-Like Properties and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/909001 [patent_app_country] => US [patent_app_date] => 2006-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 23420 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20090017447.pdf [firstpage_image] =>[orig_patent_app_number] => 11909001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5397355 [patent_doc_number] => 20090317418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'VACCINES AND METHODS FOR PREVENTION AND TREATMENT OF DRUG-RESISTANT HIV-1 AND HEPATITIS B VIRUS' [patent_app_type] => utility [patent_app_number] => 11/816704 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 33109 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317418.pdf [firstpage_image] =>[orig_patent_app_number] => 11816704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391612 [patent_doc_number] => 20090208925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Methods and Compositions for Determining Hypersusceptibility of HIV-1 to Non-Nucleoside Reverse Transcriptase Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/884667 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18962 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208925.pdf [firstpage_image] =>[orig_patent_app_number] => 11884667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 602167 [patent_doc_number] => 07431928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-07 [patent_title] => 'Identification of new CD8 epitopes from HIV-1 proteins' [patent_app_type] => utility [patent_app_number] => 11/339605 [patent_app_country] => US [patent_app_date] => 2006-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 8254 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/431/07431928.pdf [firstpage_image] =>[orig_patent_app_number] => 11339605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5873008 [patent_doc_number] => 20060165717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'DCchol in newborns' [patent_app_type] => utility [patent_app_number] => 11/338908 [patent_app_country] => US [patent_app_date] => 2006-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2567 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165717.pdf [firstpage_image] =>[orig_patent_app_number] => 11338908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5699622 [patent_doc_number] => 20060216306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Epitopes of human immunodeficiency virus-1' [patent_app_type] => utility [patent_app_number] => 11/302312 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9345 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216306.pdf [firstpage_image] =>[orig_patent_app_number] => 11302312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404480 [patent_doc_number] => 20090239794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'HCV F PROTEIN AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/719635 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 26450 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239794.pdf [firstpage_image] =>[orig_patent_app_number] => 11719635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5148760 [patent_doc_number] => 20070048820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion' [patent_app_type] => utility [patent_app_number] => 11/258963 [patent_app_country] => US [patent_app_date] => 2005-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15601 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20070048820.pdf [firstpage_image] =>[orig_patent_app_number] => 11258963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9238219 [patent_doc_number] => 08603006 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Method and apparatus for detecting ineffective inspiratory efforts and improving patient-ventilator interaction' [patent_app_type] => utility [patent_app_number] => 11/664730 [patent_app_country] => US [patent_app_date] => 2005-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 5989 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11664730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5799367 [patent_doc_number] => 20060034868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Methods and vaccines for providing in ovo protection against turkey rhinotracheitis' [patent_app_type] => utility [patent_app_number] => 11/251692 [patent_app_country] => US [patent_app_date] => 2005-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15741 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20060034868.pdf [firstpage_image] =>[orig_patent_app_number] => 11251692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748619 [patent_doc_number] => 20060111551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Peptide having HTLV-1-specific CTL-inducing activity' [patent_app_type] => utility [patent_app_number] => 11/251195 [patent_app_country] => US [patent_app_date] => 2005-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13190 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111551.pdf [firstpage_image] =>[orig_patent_app_number] => 11251195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5807269 [patent_doc_number] => 20060093623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Subtype-matched inactivated whole virus vaccines for treating patients with HIV infection' [patent_app_type] => utility [patent_app_number] => 11/243094 [patent_app_country] => US [patent_app_date] => 2005-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5128 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20060093623.pdf [firstpage_image] =>[orig_patent_app_number] => 11243094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5648401 [patent_doc_number] => 20060134133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'MVA expressing modified HIV envelope, Gag, and Pol genes' [patent_app_type] => utility [patent_app_number] => 11/238155 [patent_app_country] => US [patent_app_date] => 2005-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 67 [patent_no_of_words] => 24717 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134133.pdf [firstpage_image] =>[orig_patent_app_number] => 11238155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776397 [patent_doc_number] => 20120039923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'Modified HIV-1 Envelope Proteins' [patent_app_type] => utility [patent_app_number] => 11/662422 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11979 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039923.pdf [firstpage_image] =>[orig_patent_app_number] => 11662422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743133 [patent_doc_number] => 20060088858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Modified venom and venom components as anti-retroviral agents' [patent_app_type] => utility [patent_app_number] => 11/217713 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7301 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088858.pdf [firstpage_image] =>[orig_patent_app_number] => 11217713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4898880 [patent_doc_number] => 20080118494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Compositions For Detection Of Latent Hiv Reactivation And Methods Of Using The Same' [patent_app_type] => utility [patent_app_number] => 11/661881 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21096 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20080118494.pdf [firstpage_image] =>[orig_patent_app_number] => 11661881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859150 [patent_doc_number] => 20080268000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Vaccine Stabilising Formula with Live Antigens for Use in Mass Vaccination Systems' [patent_app_type] => utility [patent_app_number] => 12/065216 [patent_app_country] => US [patent_app_date] => 2005-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5971 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20080268000.pdf [firstpage_image] =>[orig_patent_app_number] => 12065216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5726860 [patent_doc_number] => 20060057620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Treatment of HIV infection' [patent_app_type] => utility [patent_app_number] => 11/212906 [patent_app_country] => US [patent_app_date] => 2005-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3845 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057620.pdf [firstpage_image] =>[orig_patent_app_number] => 11212906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5533042 [patent_doc_number] => 20090232830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Modified HIV-1 Envelope Proteins' [patent_app_type] => utility [patent_app_number] => 11/661210 [patent_app_country] => US [patent_app_date] => 2005-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17248 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232830.pdf [firstpage_image] =>[orig_patent_app_number] => 11661210 [rel_patent_id] =>[rel_patent_doc_number] =>)